senate Bill S7694

Signed By Governor
2021-2022 Legislative Session

Relates to the screening of newborns for glucose-6-phosphate dehydrogenase deficiency

download bill text pdf

Sponsored By

Archive: Last Bill Status - Signed by Governor


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (11)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Feb 24, 2022 signed chap.70
delivered to governor
Jan 31, 2022 returned to senate
passed assembly
ordered to third reading cal.353
substituted for a8836
Jan 12, 2022 referred to health
delivered to assembly
passed senate
Jan 10, 2022 ordered to third reading cal.22
Jan 07, 2022 referred to rules

Votes

view votes

Jan 18, 2022 - Rules committee Vote

S7694
19
0
committee
19
Aye
0
Nay
1
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Rules committee vote details

Jan 10, 2022 - Rules committee Vote

S7694
19
0
committee
19
Aye
0
Nay
1
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Rules committee vote details

S7694 (ACTIVE) - Details

See Assembly Version of this Bill:
A8836
Law Section:
Public Health Law
Laws Affected:
Amd §2500-a, Pub Health L (as proposed in A.4572 & S.4316)

S7694 (ACTIVE) - Summary

Relates to the screening of newborns for glucose-6-phosphate dehydrogenase deficiency.

S7694 (ACTIVE) - Sponsor Memo

S7694 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   7694
 
                             I N  S E N A T E
 
                              January 7, 2022
                                ___________
 
 Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
   printed to be committed to the Committee on Rules
 
 AN ACT to amend the public health law, in relation to newborn  screening
   for glucose-6-phosphate dehydrogenase deficiency
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Paragraph (j) of subdivision 1 of  section  2500-a  of  the
 public  health  law,  as added by a chapter of the laws of 2021 amending
 the public health law relating to newborn screening for  adrenoleukodys-
 trophy  and glucose-6-phosphate dehydrogenase deficiency, as proposed in
 legislative bills numbers A. 4572 and S. 4316, is  amended  to  read  as
 follows:
   (j)  Glucose-6-phosphate dehydrogenase deficiency USING A QUANTITATIVE
 ENZYMATIC TEST OR OTHER DIAGNOSTIC TEST  IN  CASES  WHERE:  THE  NEWBORN
 INFANT  PRESENTS WITH HEMOLYTIC ANEMIA, HEMOLYTIC JAUNDICE, OR EARLY-ON-
 SET INCREASING NEONATAL JAUNDICE, THAT  IS,  JAUNDICE  (BILIRUBIN  LEVEL
 GREATER THAN FORTIETH PERCENTILE FOR AGE IN HOURS) PERSISTING BEYOND THE
 DAY  OF  BIRTH THROUGH THE WEEK AFTER BIRTH; THE NEWBORN INFANT HAS BEEN
 ADMITTED TO THE HOSPITAL FOR JAUNDICE FOLLOWING BIRTH; OR THE BIOLOGICAL
 PARENT OF THE NEWBORN INFANT INDICATES A FAMILY, RACIAL, OR ETHNIC  RISK
 OF   GLUCOSE-6-PHOSPHATE   DEHYDROGENASE  DEFICIENCY,  INCLUDING  HAVING
 SIGNIFICANT AFRICAN, ASIAN, MEDITERRANEAN, OR MIDDLE EASTERN ANCESTRY.
   § 2. This act shall take effect on the  same  date  and  in  the  same
 manner  as  a chapter of the laws of 2021 amending the public health law
 relating   to   newborn   screening   for    adrenoleukodystrophy    and
 glucose-6-phosphate dehydrogenase deficiency, as proposed in legislative
 bills numbers A. 4572 and S.  4316, takes effect. Effective immediately,
 the commissioner of health shall make regulations and take other actions
 reasonably necessary to implement this act on that date.
 

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00136-02-2


Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.